TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/13/23 16:11 | 9/11/23 | ZNTL | Zentalis Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Skvarka Jan | NY | D | S | -125 | 25.05 | 0 | -5 | -9 | 48 | D | ||||||||||||||||
5/13/21 16:12 | 5/11/21 | TRIL | Trillium Therapeutics Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Skvarka Jan | A6 | DO | P,CEO | M.dm | 53 | 0.4026 | 0 | 131 | 0 | D | |||||||||||||||
5/13/21 16:12 | 5/11/21 | TRIL | Trillium Therapeutics Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Skvarka Jan | A6 | DO | P,CEO | S.dm | -1,202 | 9.21 | 0 | -131 | -100 | 0 | D | ||||||||||||||
1/15/21 16:19 | 1/13/21 | TRIL | Trillium Therapeutics Inc. | A6 | Health | Drug | Pharmaceutical Preparations | Skvarka Jan | A6 | DO | P,CEO | M.dm | 11 | 0.4269 | 0 | 25 | 0 | D | |||||||||||||||
1/15/21 16:19 | 1/13/21 | TRIL | Trillium Therapeutics Inc. | A6 | Health | Drug | Pharmaceutical Preparations | Skvarka Jan | A6 | DO | P,CEO | S.dm | -376 | 15.03 | 0 | -25 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |